|
MRPS23 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.214200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.701610E-01 |
| Normal-vs-Stage2 |
5.369200E-01 |
| Normal-vs-Stage3 |
3.120600E-01 |
| Normal-vs-Stage4 |
6.165800E-01 |
| Stage1-vs-Stage2 |
3.910100E-02 |
| Stage1-vs-Stage3 |
7.882000E-01 |
| Stage1-vs-Stage4 |
5.378600E-01 |
| Stage2-vs-Stage3 |
1.013650E-01 |
| Stage2-vs-Stage4 |
2.806000E-01 |
| Stage3-vs-Stage4 |
6.703200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.435000E-01 |
| Normal-vs-AfricanAmerican |
5.599000E-01 |
| Normal-vs-Asian |
2.342400E-01 |
| Caucasian-vs-AfricanAmerican |
8.345400E-01 |
| Caucasian-vs-Asian |
7.517600E-01 |
| AfricanAmerican-vs-Asian |
7.034200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.016800E-01 |
| Normal-vs-Female |
2.319600E-01 |
| Male-vs-Female |
2.979000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.065200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.162000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.035000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.983600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.310800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.730200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.433200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.738400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.930000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.580200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.031370E-01 |
| Classical-VS-Follicular |
1.05090000002139E-06 |
| Classical-VS-Other |
9.871800E-01 |
| Classical-VS-Normal |
7.356100E-02 |
| Tall-VS-Follicular |
1.80940000005236E-06 |
| Tall-VS-Other |
5.565000E-01 |
| Tall-VS-Normal |
3.764500E-03 |
| Follicular-VS-Other |
1.646380E-01 |
| Follicular-VS-Normal |
7.256400E-02 |
| Other-VS-Normal |
4.783600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.211600E-01 |
| Normal-vs-N1 |
9.494600E-01 |
| N0-vs-N1 |
7.110400E-01 |
|
|
